How should sliding‑scale insulin be calculated and administered for a 70‑kg hospitalized patient with a blood glucose of 250 mg/dL?

Sliding Scale Insulin: Overview and Clinical Application

Sliding scale insulin (SSI) alone should NOT be used for most hospitalized patients with diabetes, particularly those with type 1 diabetes or established type 2 diabetes, as it provides inferior glycemic control and increases complications compared to scheduled basal-bolus regimens. 1

What is Sliding Scale Insulin?

SSI is a reactive approach where rapid-acting insulin is given in response to elevated blood glucose without regard to:

• Timing of meals
• Pre-existing insulin administration
• Individual insulin sensitivity 2

This "treat after the fact" strategy has been condemned in clinical guidelines despite continued widespread use 1.

When SSI May Be Appropriate (Limited Scenarios)

SSI alone is acceptable only for:

• Patients WITHOUT diabetes who develop mild stress hyperglycemia during hospitalization 1
• Patients with good baseline control on oral medications at home who develop mild hyperglycemia 1
• Patients with bedtime glucose <300 mg/dL where bedtime rapid-acting insulin may be unnecessary 3

Critical caveat: Even in these limited scenarios, if glucose cannot be maintained below 180 mg/dL with SSI alone, basal insulin must be added 1.

Why SSI Alone Fails in Most Patients

Randomized trials consistently demonstrate that SSI alone results in:

• Clinically significant hyperglycemia in most patients 1
• Increased postoperative complications including wound infections, pneumonia, bacteremia, and renal/respiratory failure compared to basal-bolus regimens 1
• Poor overall glycemic control 1

However, SSI does have one advantage: 4-6 times lower hypoglycemia risk compared to basal-bolus insulin (RR 5.75 for glucose ≤70 mg/dL; RR 4.21 for glucose ≤60 mg/dL) 1.

For Your 70-kg Patient with Glucose 250 mg/dL

If This Patient Has Type 2 Diabetes:

Do NOT use SSI alone. Instead, use a basal-plus regimen:

• Basal insulin: 0.1-0.25 U/kg/day = 7-17.5 units once daily 1
• Plus correction insulin before meals or every 6 hours if NPO 1

If This Patient Has Type 1 Diabetes:

SSI alone is absolutely contraindicated. Use basal-bolus regimen:

• Total daily dose: 0.3-0.5 U/kg = 21-35 units/day for this 70-kg patient 1
• Split: 50% as basal (once or twice daily), 50% as rapid-acting before meals (divided three times daily) 1
• Plus correction doses of rapid-acting insulin 1

If This Patient Has NO Diabetes (Stress Hyperglycemia):

SSI alone may be appropriate initially, but:

• Monitor closely
• Add basal insulin if unable to maintain glucose <180 mg/dL 1

Key Dosing Modifications

Lower the dose (toward 0.1-0.3 U/kg) for patients at high hypoglycemia risk:

• Age >65 years
• Renal failure
• Poor oral intake 1

Reduce home insulin by 20% if patient was on ≥0.6 U/kg/day at home to prevent hypoglycemia with reduced hospital intake 1

Common Pitfalls to Avoid

1. Never use SSI alone in type 1 diabetes - these patients have zero endogenous insulin production and require basal coverage 1

2. Don't continue SSI if glucose remains >180 mg/dL - this indicates need for scheduled insulin 1

3. Avoid premixed insulin (70/30) in hospitals - unacceptably high hypoglycemia rates 1

4. Don't use bedtime rapid-acting insulin for glucose <300 mg/dL - evidence shows it's unnecessary and may cause nocturnal hypoglycemia 3

The Bottom Line

While SSI has lower hypoglycemia risk, this safety advantage does not outweigh the poor glycemic control and increased complications in patients with established diabetes. The evidence strongly favors scheduled insulin regimens (basal-plus or basal-bolus) for most hospitalized patients, reserving SSI alone for the narrow population of non-diabetic patients with mild stress hyperglycemia 1.